Investors Watch List: QuinStreet, Inc. (NASDAQ:QNST), Penn West Petroleum Ltd. (NYSE:PWE), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Ocean Power Technologies, Inc.

QuinStreet, Inc. (NASDAQ:QNST) announced that it has signed a 10-year partnership agreement with All Web Leads (“AWL”) to be the exclusive provider of click product technologies and management to AWL. AWL is the largest online customer acquisition marketing company focused on the U.S. insurance industry and recently acquired the Bankrate Insurance customer acquisition business.

QuinStreet, Inc. (NASDAQ:QNST) belongs to Technology sector. Its net profit margin is -7.20% and weekly performance is 7.80%. On last trading day company shares ended up at $3.04. QuinStreet, Inc. (NASDAQ:QNST) distance from 50-day simple moving average (SMA50) is -0.03%.

On 10 February, Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) announced financial and operational results for the fourth quarter and full year ended December 31, 2015. Fanapt® net product sales were $16.7 million for the fourth quarter of 2015, compared to $16.7 million in the third quarter of 2015.

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) shares increased 0.91% in last trading session and ended the day at $7.74. VNDA Gross Margin is 78.60% and its return on assets is -18.30%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) quarterly performance is -20.12%.

On 16 February, Penn West Petroleum Ltd. (NYSE:PWE) has reached agreements to settle a bevy of class-action lawsuits stemming from accounting. The settlement in the Canadian and U.S. cases will be fully funded by the company’s insurance, meaning its cash resources and financial position won’t take a hit.

Penn West Petroleum Ltd. (NYSE:PWE) belongs to Basic Materials sector. Its weekly performance is -2.06%. On last trading day company shares ended up at $0.95. Penn West Petroleum Ltd. (NYSE:PWE) distance from 50-day simple moving average (SMA50) is 6.94%.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) will webcast its Quarterly Update Conference Call for the fourth quarter and full year 2015 on Monday, February 29 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date post-market, Halozyme will release financial results for the fourth quarter and year-ended December 31, 2015.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares fell -1.26% in last trading session and ended the day at $7.81. HALO Gross Margin is 76.10% and its return on assets is -25.50%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) quarterly performance is -55.70%.

Ocwen Financial Corp. (NYSE:OCN) will hold a conference call on Monday, February 29, 2016 at 5:00 p.m. (ET) to review the Company’s 4th Quarter 2015 operating results. These events will follow Ocwen’s 4th Quarter 2015 earnings release.

Ocwen Financial Corp. (NYSE:OCN) shares increased 4.04% in last trading session and ended the day at $6.18. OCN Gross Margin is 82.40% and its return on assets is -6.70%. Ocwen Financial Corp. (NYSE:OCN) quarterly performance is -4.63%.

Leave a Reply

Your email address will not be published. Required fields are marked *